IRCT2017091529374N1CompletedPhase 2
Study the effect of Dehydroepiandrosterone on the ovarian reserve rates and serum anti-Mullerian hormone levels in infertile women with diminished ovarian reserve.
Vice chancellor of Mazandaran University of Medical Science.0 sites70 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 years to 45 years (—)
- Sex
- Female
Inclusion Criteria
- •Infertile women aged 20 to 45 years; normal hysterosalpingography; AMH levels < 1.5 ng/ml; antral follicular counts (AFC) < 7 in both ovaries; prior less than three failed in vitro fertilization cycles. Exclusion criteria: Normal ovarian response in ovulatory cycles or in vitro fertilization cycles.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Not Applicable
DHEA hormone to treat ovarian agingEUCTR2011-002425-21-GBniversity of Nottingham
Completed
Not Applicable
The effect of dehydroepiandrosterone on quality of liferheumatoid arthritis.Seropositive rheumatoid arthritisIRCT2017052134062N1Vice chancellor for research, Zahedan University of Medical Sciences46
Not yet recruiting
Phase 2
The effect Dehydroepiandrosterone (DHEA) supplementation on IVF outcomeIRCT20160523028008N14Hamedan University of Medical Sciences80
Completed
Not Applicable
Immune effects of dehydroepiandrosterone (DHEA) in adrenal insufficiency (IDHEAL)ISRCTN18758725Department of Health50
Completed
Unknown
The role of hormones in acute coronary syndrome (heart attack)Circulatory SystemAcute coronary syndromeISRCTN62480360Medical University of Sofia175